ACT Genomics is an integrated cancer molecular information company that provides comprehensive NGS-based genomic profiling and a proprietary pathway-based data approach to optimizing clinical treatment decisions and assists biomarker exploration to oncology-focused biopharma developing targeted therapies and immune-checkpoint inhibitors more effectively.
URL:
prnewswire.com/news-releases/act-genomics-astrazeneca-enter-collaboration-for-brca-testing-in-singapore-and-taiwan-300591794.html
URL:
prnewswire.com/news-releases/act-genomics-astrazeneca-enter-collaboration-for-brca-testing-in-singapore-and-taiwan-300591794.html
No comments:
Post a Comment